PH23767A - Cephem compunds,pharmaceutical composition containing same and method of use therof - Google Patents

Cephem compunds,pharmaceutical composition containing same and method of use therof

Info

Publication number
PH23767A
PH23767A PH35750A PH35750A PH23767A PH 23767 A PH23767 A PH 23767A PH 35750 A PH35750 A PH 35750A PH 35750 A PH35750 A PH 35750A PH 23767 A PH23767 A PH 23767A
Authority
PH
Philippines
Prior art keywords
compunds
cephem
pharmaceutical composition
composition containing
containing same
Prior art date
Application number
PH35750A
Other languages
English (en)
Inventor
Takao Takaya
Kazuo Sakane
Kenzi Miyai
Kohji Kawabata
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868622766A external-priority patent/GB8622766D0/en
Priority claimed from GB868628061A external-priority patent/GB8628061D0/en
Priority claimed from GB878705072A external-priority patent/GB8705072D0/en
Priority claimed from GB878711653A external-priority patent/GB8711653D0/en
Priority claimed from GB878716437A external-priority patent/GB8716437D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PH23767A publication Critical patent/PH23767A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH35750A 1986-09-22 1987-08-31 Cephem compunds,pharmaceutical composition containing same and method of use therof PH23767A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB868622766A GB8622766D0 (en) 1986-09-22 1986-09-22 Cephem compounds
GB868628061A GB8628061D0 (en) 1986-11-24 1986-11-24 Cephem compounds
GB878705072A GB8705072D0 (en) 1987-03-04 1987-03-04 Cephem compounds
GB878711653A GB8711653D0 (en) 1987-05-18 1987-05-18 Cephem compounds
GB878716437A GB8716437D0 (en) 1987-07-13 1987-07-13 Cephem compounds

Publications (1)

Publication Number Publication Date
PH23767A true PH23767A (en) 1989-11-03

Family

ID=27516672

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35750A PH23767A (en) 1986-09-22 1987-08-31 Cephem compunds,pharmaceutical composition containing same and method of use therof

Country Status (19)

Country Link
US (2) US4927818A (xx)
EP (1) EP0261615B1 (xx)
JP (2) JPH064647B2 (xx)
KR (1) KR950013566B1 (xx)
CN (1) CN87106452A (xx)
AU (2) AU607157B2 (xx)
CA (1) CA1293719C (xx)
DE (1) DE3788261T2 (xx)
DK (1) DK460087A (xx)
ES (1) ES2061462T3 (xx)
FI (1) FI87925C (xx)
HU (1) HU202540B (xx)
IE (1) IE872329L (xx)
IL (1) IL83760A (xx)
NO (1) NO171852C (xx)
NZ (1) NZ221843A (xx)
OA (1) OA08665A (xx)
PH (1) PH23767A (xx)
PT (1) PT85762B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5162520A (en) * 1986-09-22 1992-11-10 Fujisawa Pharmaceutical Co., Ltd. Intermediates for cephem compounds
IL86941A (en) * 1987-07-10 1993-07-08 Gist Brocades Nv Process for the preparation of cephem compounds and some new cephalosporin derivatives prepared by this process
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
US5210080A (en) * 1987-09-07 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
KR910015587A (ko) * 1990-02-27 1991-09-30 후지사와 토모키치로 세펨 화합물
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
RU2003134629A (ru) * 2001-05-01 2005-06-10 Фудзисава Фармасьютикал Ко., Лтд. (Jp) Фудзисава Фармасьютикал Ко., Лтд. (Jp) Соединения цефема
EP1556389B9 (en) * 2002-10-30 2015-09-09 Astellas Pharma Inc. Cephem compounds
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
ES2340928T3 (es) * 2003-09-18 2010-06-11 Astellas Pharma Inc. Compuestos de cefem.
JP4758371B2 (ja) * 2007-02-23 2011-08-24 株式会社荻野精機製作所 動力伝達切換機構
EP3616695B1 (en) 2011-09-09 2024-10-23 Merck Sharp & Dohme LLC Ceftolozane/tazobactam for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN102875572B (zh) * 2012-10-26 2014-07-30 四川科伦药物研究有限公司 一种硫酸头孢噻利中间体的精制方法
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
CN105377812B (zh) 2013-06-21 2018-09-18 组合化学工业株式会社 2-氨基-2-肟基-n-烷氧基亚氨代乙酰基氰化物的制备方法及其制备中间体
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US9695196B2 (en) * 2014-06-20 2017-07-04 Merck Sharp & Dohme Corp. Reactions of thiadiazolyl-oximinoacetic acid derivative compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268509A (en) * 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
NO793688L (no) * 1978-11-15 1980-05-19 Glaxo Group Ltd Fremgangsmaate ved fremstilling av cephalosporinderivater
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
US4332800A (en) * 1979-10-12 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
GR78245B (xx) * 1980-09-12 1984-09-26 Ciba Geigy Ag
ZA816321B (en) * 1980-09-12 1982-09-29 Ciba Geigy Ammoniomethyl compounds,processes for their manufacture,pharmaceutical preparations that contain these compounds,and the use of these compounds
US4431642A (en) * 1980-12-01 1984-02-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
EP0062321B1 (en) * 1981-04-03 1989-03-01 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
JPS584789A (ja) * 1981-04-03 1983-01-11 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法
GR75487B (xx) * 1981-06-22 1984-07-23 Fujisawa Pharmaceutical Co
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3419012A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel oder wachstumsfoerderer in der tieraufzucht oder als antioxidantien
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds
JPS61286389A (ja) * 1985-06-11 1986-12-16 Eisai Co Ltd セフエム系化合物
CN86107947A (zh) * 1985-11-22 1987-05-27 藤沢药品工业株式会社 新的头孢烯化合物及其制备方法
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
IE63094B1 (en) * 1987-09-14 1995-03-22 Fujisawa Pharmaceutical Co Cephem compound and a process for preparation thereof

Also Published As

Publication number Publication date
KR950013566B1 (ko) 1995-11-09
DK460087D0 (da) 1987-09-03
FI87925B (fi) 1992-11-30
EP0261615A3 (en) 1989-09-20
DE3788261D1 (de) 1994-01-05
OA08665A (en) 1988-11-30
NO171852B (no) 1993-02-01
CA1293719C (en) 1991-12-31
AU6707790A (en) 1991-02-14
US4927818A (en) 1990-05-22
HUT45071A (en) 1988-05-30
DK460087A (da) 1988-03-23
NO873640L (no) 1988-03-23
FI874102A0 (fi) 1987-09-21
KR880003958A (ko) 1988-06-01
JPH064647B2 (ja) 1994-01-19
AU7867187A (en) 1988-03-24
HU202540B (en) 1991-03-28
NO171852C (no) 1993-05-12
US5108997A (en) 1992-04-28
DE3788261T2 (de) 1994-04-07
PT85762B (pt) 1990-07-31
IE872329L (en) 1988-03-22
AU642929B2 (en) 1993-11-04
NO873640D0 (no) 1987-08-28
NZ221843A (en) 1989-08-29
AU607157B2 (en) 1991-02-28
CN87106452A (zh) 1988-05-04
IL83760A0 (en) 1988-02-29
EP0261615B1 (en) 1993-11-24
JPS6399079A (ja) 1988-04-30
IL83760A (en) 1993-04-04
FI87925C (fi) 1993-03-10
FI874102A (fi) 1988-03-23
JPH0656846A (ja) 1994-03-01
JPH0680064B2 (ja) 1994-10-12
EP0261615A2 (en) 1988-03-30
ES2061462T3 (es) 1994-12-16
PT85762A (en) 1987-10-01

Similar Documents

Publication Publication Date Title
PH23767A (en) Cephem compunds,pharmaceutical composition containing same and method of use therof
PH24719A (en) Cephem compound, pharmaceutical composition containing said compound and method of use thereof
DE3660704D1 (en) Surfactant composition, process for its preparation and its use
EP0224445A3 (en) Compositions of matter, their preparation process and their use
PH22672A (en) Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
PH24749A (en) Piperidine compounds, pharmaceutical composition and method of use thereof
PH23341A (en) Morphinane derivatives,pharmaceutical composition containing said compounds and method of use thereof
PH24180A (en) Macrolide compounds,pharmaceutical composition containing said compound and method of use thereof
IL83357A0 (en) Renin-inhibiting peptides,process for their preparation,agents containing them,and their use
ZA885782B (en) Aralkylaminoalkoxyphenyl derivatives,process of preparation and compositions containing the same
PH24093A (en) Macrolide compounds,pharmaceutical composition containing same and method of use thereof
EP0256608A3 (en) Method of preparation and use of solid, phytoactive compositions
AR244216A1 (es) Iminofeniltiazolidinas, procedimiento de preparacion y metodo de uso.
PH23367A (en) Purine derivatives,composition and method of use thereof
PH24290A (en) Pyrimidine derivatives,pharmaceutical compositions containing them and method of use thereof
GR861027B (en) (-)-1b-ethyl-1a-hydroxymethyl-1,2,3,4,6,7,12,12ba-octahydroindolo(2,3-a) quinolizine process for its preparation and pharmaceutical compositions containing same
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
PH22247A (en) Diazepinoindole, pharmaceutical composition and method of use thereof
IL86884A0 (en) Method of preparation of nucleic acid derivatives and method of preparation of medical composition containing the same
PH24246A (en) New 1-aryloxy-dihydrobenzothiadiazinylalkylamino-alkanes,pharmaceutical compositions containing same and method of use thereof
PH17497A (en) 7-(carboxymethoximino)-1h-pyrazol-3yl amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5yl-thio)cephalosporanic acid,pharmaceutical composition containing same and their use
PH24690A (en) 8 alpha(-acylaminoergoline, pharmaceutical composition containing said compound and method of use thereof
PH25227A (en) Aromatic w-alkylamino-tetrahydro-6h-1,3-thiazin-6-one derivatives, pharmaceutical composition containing same and method of use thereof
PH22671A (en) Alkeneamidocephalosporin esters, pharmaceutical composition containing same and method of use thereof
PH22684A (en) Antihypertensive agents, pharmaceutical compositions containing them and method of use thereof